Correlation Between Seres Therapeutics and XBiotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and XBiotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and XBiotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and XBiotech, you can compare the effects of market volatilities on Seres Therapeutics and XBiotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of XBiotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and XBiotech.

Diversification Opportunities for Seres Therapeutics and XBiotech

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Seres and XBiotech is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and XBiotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XBiotech and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with XBiotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XBiotech has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and XBiotech go up and down completely randomly.

Pair Corralation between Seres Therapeutics and XBiotech

Given the investment horizon of 90 days Seres Therapeutics is expected to generate 1.83 times more return on investment than XBiotech. However, Seres Therapeutics is 1.83 times more volatile than XBiotech. It trades about 0.12 of its potential returns per unit of risk. XBiotech is currently generating about 0.0 per unit of risk. If you would invest  81.00  in Seres Therapeutics on September 4, 2024 and sell it today you would earn a total of  12.00  from holding Seres Therapeutics or generate 14.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Seres Therapeutics  vs.  XBiotech

 Performance 
       Timeline  
Seres Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Seres Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Seres Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
XBiotech 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in XBiotech are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating forward indicators, XBiotech unveiled solid returns over the last few months and may actually be approaching a breakup point.

Seres Therapeutics and XBiotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Seres Therapeutics and XBiotech

The main advantage of trading using opposite Seres Therapeutics and XBiotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, XBiotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XBiotech will offset losses from the drop in XBiotech's long position.
The idea behind Seres Therapeutics and XBiotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing